PT-141 SPRAY
A 7-amino acid cyclic peptide analog of alpha-MSH that activates melanocortin receptors MC3R and MC4R, FDA-approved for hypoactive sexual desire disorder and studied for sexual function in clinical research. Premium Research Peptide.
$54.99
|
15MG
|
Verified Test Results
Every batch, independently verified.
Each batch is analyzed by an ISO/IEC 17025 accredited third-party laboratory. The report below reflects the identity, purity and full-panel specification data released with this product.
Certificate of Analysis
Purity by HPLC
| Parameter | Result | Specification |
|---|---|---|
| Appearance | Good | Meets spec |
| Purity | 99.91% · Pass | ≥ 95% |
| Net Peptide Content | 10.61mg | Report |
| Identity | Confirmed | Meets spec |
| Fentanyl Screen | Not Detected | Pass |
| Heavy Metals | Not Detected | Pass |
| Sterility | No Growth | Pass |
| Endotoxin | < 0.05 EU/mL | Reported |
Representative report from lot PT0002 (PT-141 SPRAY). Your order ships with its own lot-specific certificate.
View this batch's certificateThird-party verified
Certificate of Analysis
Every lot is HPLC-tested at an ISO/IEC 17025-accredited lab. Open any batch's certificate below.
Compound Information
Technical specifications
What Is PT-141?
Cyclic heptapeptide analog of alpha-MSH, active metabolite of Melanotan II
Handling & Storage
Supplied ready to use. No reconstitution required.
Regulatory Information
Developed by Palatin Technologies, approved by FDA
Sources & References
Peer-reviewed research
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
Kingsberg SA, Clayton AH, Portman D, et al.
PT-141: a melanocortin agonist for the treatment of sexual dysfunction
Diamond LE, Earle DC, Rosen RC, et al.
An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist
Diamond LE, Earle DC, Heiman JR, et al.
Reported Event Profile of Bremelanotide Across the Clinical Development Program
Vyleesi (bremelanotide) Prescribing Information
Bremelanotide for Treatment of Female Hypoactive Sexual Desire Disorder
Bremelanotide - Compound Summary (CID 9941379)
Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
Frequently asked questions
A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.
Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.
A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.
Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.